[1]
“Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years”, Swiss Med Wkly, vol. 149, no. 2526, p. w20085, Jun. 2019, doi: 10.4414/smw.2019.20085.